Akagi Y - Search Results

1

[Two Cases of Effective Hepatic Arterial Infusion Chemotherapy for Liver Metastases of Colon Cancer Resistant to Systemic Chemotherapy].

Date Y, Hisaka T, Takahashi K, Nakayama G, Akashi M, Kawahara R, Sakai H, Ishikawa H, Yasunaga M, Uchida S, Horiuchi H, Okuda K, Matsunaga M, Miwa K, Akagi Y. Date Y, et al. Among authors: akagi y. Gan To Kagaku Ryoho. 2015 Nov;42(12):1518-20. Gan To Kagaku Ryoho. 2015. PMID: 26805082 Japanese.

2

Hepatic arterial chemotherapy for liver metastases from colorectal cancer.

Ogata Y, Shirouzu K, Akagi Y, Hiraki M, Isomoto H. Ogata Y, et al. Among authors: akagi y. Kurume Med J. 1996;43(1):41-7. doi: 10.2739/kurumemedj.43.41. Kurume Med J. 1996. PMID: 8709558 Free article.

3

[Relationship between the anti-metastatic effect of UFT and in vitro chemosensitivity to 5-FU in metastatic tumors from orthotopic implanted colon cancer in nude rats].

Ogata Y, Akagi Y, Nozoe Y, Sasatomi T, Miyagi Y, Nakagawa M, Matono K, Kobayashi H, Shirouzu K. Ogata Y, et al. Among authors: akagi y. Gan To Kagaku Ryoho. 2001 May;28(5):655-60. Gan To Kagaku Ryoho. 2001. PMID: 11383214 Japanese.

4

Long-term survival following treatment with antineoplastons for colon cancer with unresectable multiple liver metastases: report of a case.

Ogata Y, Tsuda H, Matono K, Kumabe T, Saitsu H, Hara H, Akagi Y, Araki Y, Sata M, Shirouzu K. Ogata Y, et al. Among authors: akagi y. Surg Today. 2003;33(6):448-53. doi: 10.1007/s10595-002-2503-2. Surg Today. 2003. PMID: 12768372

5

The expression of vascular endothelial growth factor determines the efficacy of post-operative adjuvant chemotherapy using oral fluoropyrimidines in stage II or III colorectal cancer.

Ogata Y, Matono K, Mizobe T, Ishibashi N, Mori S, Akagi Y, Ikeda S, Ozasa H, Murakami H, Shirouzu K. Ogata Y, et al. Among authors: akagi y. Oncol Rep. 2006 May;15(5):1111-6. Oncol Rep. 2006. PMID: 16596171

6

Metronomic chemotherapy using weekly low-dosage CPT-11 and UFT as postoperative adjuvant therapy in colorectal cancer at high risk to recurrence.

Ogata Y, Mori S, Ishibashi N, Akagi Y, Ushijima M, Murakami H, Fukushima T, Shirouzu K. Ogata Y, et al. Among authors: akagi y. J Exp Clin Cancer Res. 2007 Dec;26(4):475-82. J Exp Clin Cancer Res. 2007. PMID: 18365541

7

Intraoperative thermal ablation therapy for small colorectal metastases to the liver.

Ogata Y, Uchida S, Hisaka T, Horiuchi H, Mori S, Ishibashi N, Akagi Y, Shirouzu K. Ogata Y, et al. Among authors: akagi y. Hepatogastroenterology. 2008 Mar-Apr;55(82-83):550-6. Hepatogastroenterology. 2008. PMID: 18613406

8

Efficacy of the combined use of bevacizumab and irinotecan as a postoperative adjuvant chemotherapy in colon carcinoma.

Mizobe T, Ogata Y, Murakami H, Akagi Y, Ishibashi N, Mori S, Sasatomi T, Shirouzu K. Mizobe T, et al. Among authors: akagi y. Oncol Rep. 2008 Sep;20(3):517-23. Oncol Rep. 2008. PMID: 18695900

9

Elevated preoperative serum carcinoembrionic antigen level may be an effective indicator for needing adjuvant chemotherapy after potentially curative resection of stage II colon cancer.

Ogata Y, Murakami H, Sasatomi T, Ishibashi N, Mori S, Ushijima M, Akagi Y, Shirouzu K. Ogata Y, et al. Among authors: akagi y. J Surg Oncol. 2009 Jan 1;99(1):65-70. doi: 10.1002/jso.21161. J Surg Oncol. 2009. PMID: 18942720

10

[Therapeutic results of hepatic resection using thermal ablation for unresectable colorectal liver metastases].

Murakami H, Ogata Y, Uchida S, Sasatomi T, Murakami N, Yamaguchi K, Gotanda Y, Akagi Y, Ishibashi N, Shirouzu K. Murakami H, et al. Among authors: akagi y. Gan To Kagaku Ryoho. 2009 Nov;36(12):2039-41. Gan To Kagaku Ryoho. 2009. PMID: 20037316 Japanese.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

637 results

Search Page

Filters